Guardant Current Deferred Revenue vs Total Current Assets Analysis
GH Stock | USD 35.10 0.73 2.12% |
Guardant Health financial indicator trend analysis is much more than just examining Guardant Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Guardant Health is a good investment. Please check the relationship between Guardant Health Current Deferred Revenue and its Total Current Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Current Deferred Revenue vs Total Current Assets
Current Deferred Revenue vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Guardant Health Current Deferred Revenue account and Total Current Assets. At this time, the significance of the direction appears to have strong relationship.
The correlation between Guardant Health's Current Deferred Revenue and Total Current Assets is 0.73. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Guardant Health, assuming nothing else is changed. The correlation between historical values of Guardant Health's Current Deferred Revenue and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Guardant Health are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Current Deferred Revenue i.e., Guardant Health's Current Deferred Revenue and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.73 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Guardant Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Tax Provision is increasing as compared to previous years. The Guardant Health's current Issuance Of Capital Stock is estimated to increase to about 517.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 22.3M | 36.0M | 42.9M | 45.0M | Interest Income | 3.9M | 6.1M | 35.4M | 37.1M |
Guardant Health fundamental ratios Correlations
Click cells to compare fundamentals
Guardant Health Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Guardant Health fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 962.5M | 2.3B | 2.2B | 1.6B | 1.8B | 1.4B | |
Short Long Term Debt Total | 33.3M | 847.9M | 1.4B | 1.4B | 1.4B | 685.2M | |
Other Current Liab | 37.1M | 39.7M | 148.7M | 85.0M | 108.3M | 63.1M | |
Total Current Liabilities | 72.7M | 66.8M | 194.7M | 193.2M | 205.9M | 112.0M | |
Total Stockholder Equity | 798.4M | 1.3B | 645.0M | 60.2M | 158.7M | 150.7M | |
Other Liab | 8.6M | 1.5M | 3.9M | 9.2M | 8.3M | 6.7M | |
Net Tangible Assets | 779.7M | 1.3B | 627.5M | 45.2M | 51.9M | 49.3M | |
Property Plant And Equipment Net | 72.8M | 100.1M | 313.9M | 341.9M | 302.7M | 163.8M | |
Current Deferred Revenue | 12.3M | 8.6M | 11.3M | 17.4M | 18.0M | 12.2M | |
Net Debt | (110.0M) | 14.9M | 868.7M | 1.2B | 220.2M | 274.0M | |
Retained Earnings | (352.8M) | (606.6M) | (1.0B) | (1.7B) | (2.1B) | (2.0B) | |
Accounts Payable | 16.2M | 7.3M | 17.6M | 68.9M | 51.7M | 54.3M | |
Cash | 143.2M | 833.0M | 492.2M | 141.6M | 1.1B | 1.2B | |
Non Current Assets Total | 365.2M | 383.4M | 1.1B | 418.4M | 439.3M | 402.7M | |
Non Currrent Assets Other | 4.9M | 17.2M | 60.9M | 61.5M | 124.2M | 130.4M | |
Other Assets | 4.9M | 17.2M | 60.9M | 36.5M | 41.9M | 44.0M | |
Cash And Short Term Investments | 522.8M | 1.8B | 932.7M | 1.0B | 1.2B | 847.8M | |
Net Receivables | 48.0M | 53.3M | 97.7M | 97.3M | 88.8M | 60.1M | |
Common Stock Shares Outstanding | 90.6M | 97.5M | 101.3M | 102.2M | 112.0M | 92.9M | |
Short Term Investments | 379.6M | 961.9M | 440.5M | 869.6M | 35.1M | 33.3M | |
Liabilities And Stockholders Equity | 962.5M | 2.3B | 2.2B | 1.6B | 1.8B | 1.4B | |
Non Current Liabilities Total | 41.8M | 849.4M | 1.4B | 1.4B | 1.4B | 1.5B | |
Capital Surpluse | 1.2B | 1.9B | 1.7B | 1.7B | 2.0B | 1.1B | |
Capital Lease Obligations | 40.4M | 41.6M | 226.1M | 231.9M | 213.8M | 224.5M | |
Inventory | 15.2M | 22.7M | 30.7M | 51.6M | 61.9M | 65.0M | |
Other Current Assets | 11.4M | 34.9M | 106.1M | 31.5M | 27.7M | 30.2M | |
Other Stockholder Equity | 1.2B | 1.9B | 1.7B | 1.7B | 2.3B | 1.3B | |
Total Liab | 114.5M | 916.2M | 1.6B | 1.5B | 1.6B | 1.7B | |
Property Plant And Equipment Gross | 72.8M | 100.1M | 313.9M | 341.9M | 430.0M | 451.5M | |
Total Current Assets | 597.4M | 1.9B | 1.1B | 1.2B | 1.3B | 956.1M | |
Accumulated Other Comprehensive Income | 1.1M | 2.7M | (4.8M) | (19.5M) | (3.7M) | (3.9M) | |
Non Current Liabilities Other | 8.6M | 43.1M | 3.9M | 9.2M | 96.0M | 100.8M | |
Short Term Debt | 7.1M | 6.6M | 12.9M | 21.9M | 28.0M | 29.3M | |
Property Plant Equipment | 72.8M | 62.8M | 313.9M | 167.9M | 193.1M | 106.4M | |
Net Invested Capital | 798.4M | 2.1B | 1.8B | 1.2B | 1.3B | 1.2B | |
Net Working Capital | 524.6M | 1.8B | 919.4M | 998.4M | 1.1B | 950.8M | |
Intangible Assets | 15.4M | 16.2M | 14.2M | 11.7M | 9.0M | 13.1M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.28) | Revenue Per Share 5.7 | Quarterly Revenue Growth 0.339 | Return On Assets (0.16) | Return On Equity (6.09) |
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.